ليست عنوان مقالات لاتين Plasma characteristics of low-k SiOC(–H) films prepared by using plasma enhanced chemical vapor deposition from DMDMS/O2 precursors Plasma surface functionalization and dyeing kinetics of Pan-Pmma copolymers

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Plasma characteristics of low-k SiOC(–H) films prepared by using plasma enhanced chemical vapor deposition from DMDMS/O2 precursors

2

Plasma characterization and room temperature growth of carbon nanotubes and nano-onions by excimer laser ablation

3

Plasma characterization and technological application of a hollow cathode plasma source with an axial magnetic field

4

Plasma chemical preparation and characterization of perovskite-type mixed oxides

5

Plasma chemical reactions at atmospheric pressure for high efficiency use of hydrocarbon fuels

6

Plasma chemical reactions in C2H2/N2, C2H4/N2, and C2H6/N2 gas mixtures of a laboratory dielectric barrier discharge Original Research Article

7

Plasma chemotactic activity during dipyridamole induced myocardial ischemia

8

Plasma chitotriosidase activity in multiple sclerosis

9

Plasma Chitotriosidase Activity in Patients with β-Thalassemia

10

Plasma Chitotriosidase Activity Is a Marker of Recovery in Transplanted Patients Affected by (BETA)-Thalassemia major

11

Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine

12

Plasma cholecystokinin and its precursors in hepatic cirrhosis

13

Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda.

14

Plasma cholesterol-raising potency of dietary free cholesterol versus cholesteryl ester and effect of β-sitosterol

15

Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states

16

Plasma cholesteryl ester transfer and hepatic lipase activity are determinants of low high density lipoprotein cholesterol associated with insulin resistance in type 2 Diabetic and non-diabetic subjects

17

Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls

18

Plasma choline in normal newborns, infants, toddlers, and in very-low–birth-weight neonates requiring total parenteral nutrition

19

Plasma circulating fibrinogen stability and moderate beer consumption

20

Plasma Circulating Terminal Differentiation– Induced Non-Coding RNA Serves as a Biomarker in Breast Cancer

21

Plasma circulatory markers in male and female patients with coronary artery disease

22

Plasma citrulline levels and acute cellular rejection early after small bowel transplantation in pigs

23

Plasma citrulline measurement using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology

24

Plasma cleaning and activation of silicon surface in Dielectric Coplanar Surface Barrier Discharge

25

Plasma cleaning of “endless” substrates by use of a tandem dielectric barrier discharge

26

Plasma cleaning of plastic ball grid array package

27

Plasma cleaning of plastic ball grid array package

28

Plasma cleaning technique for the removal of mixed materials

29

Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans

30

Plasma clearance of chylomicrons from butterfat is not dependent on saturation: studies with butterfat fractions and other fats containing triacyiglycerols with low or high melting points

31

Plasma clearance of polyfructosan and extracellular body fluid distribution in idiopathic dilated cardiomyopathy and after heart transplantation

32

Plasma clouds associated with Comet P/Borrelly dust impacts

33

Plasma coagulation factors are also non-lipid coronary heart disease risk factors

34

Plasma coagulation response to surfaces with nanoscale chemical heterogeneity

35

Plasma coatings CrAlN and a-C:H for high efficient power train in automobile

36

Plasma Coenzyme Q10 and Tocopherols in Thoroughbred Race Horses: Effect of Coenzyme Q10 Supplementation and Exercise

37

Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer

38

Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism

39

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin: A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart

40

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

41

Plasma concentration of cadmium, lead and chromium in smokers and nonsmokers in Tripoli, Libya: A comparative study

42

Plasma Concentration of Glucosamine and Chondroitin Sulfate in Horses after an Oral Dose

43

Plasma concentration of leptin and ghrelin in Standardbred foals as related to the age, sex, exercise and training

44

Plasma concentration of organochlorine compounds is associated with age and not obesity

45

Plasma Concentration of SCUBE1, a Novel Platelet Protein, Is Elevated in Patients With Acute Coronary Syndrome and Ischemic Stroke Original Research Article

46

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

47

Plasma Concentration of Soluble Vascular Cell Adhesion Molecule-1 and Oncoming Cardiovascular Risk in Patients With Unstable Angina Pectoris and Non–ST-Segment Elevation Myocardial Infarction

48

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

49

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease

50

Plasma concentrations of 15-ketodihydro-PGF2α, progesterone, oestrone sulphate, oestradiol-17β and cortisol during late gestation, parturition and the early post partum period in llamas and alpacas

51

Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome

52

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

53

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

54

Plasma concentrations of bacterial lipopolysaccharide: A marker of infection or inflammation?

55

Plasma concentrations of endothelins in cirrhosis

56

Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis

57

Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis

58

Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death

59

Plasma concentrations of immunoreactive relaxin activity and progesterone in the pregnant Asian elephant (Elephas maximus)

60

Plasma Concentrations of Inhibin A and FollicleStimulating Hormone Differ Between Cows with Two or Three Waves of Ovarian Follicular Development in a Single Estrous Cycle

61

Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling

62

Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction Original Research Article

63

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

64

Plasma concentrations of obese protein in anorexia nervosa

65

Plasma Concentrations of Oral Metronidazole in the Early Post-Laparotomy Periods

66

Plasma Concentrations of Polychlorinated Biphenyls and the Risk of Breast Cancer: A Congener-specific Analysis

67

Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass

68

Plasma concentrations of testosterone, luteinizing hormone, and estrone sulfate in stallions following hemicastration

69

Plasma concentrations of tumour necrosis factor-α and interleukin-6 during burn wound surgery or dressing

70

Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns

71

Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma

72

Plasma concentrations of β-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics

73

Plasma condensation and the one component plasma model Original Research Article

74

Plasma confinement and transport

75

Plasma confinement in JET H mode plasmas with H, D, DT and T isotopes

76

Plasma confinement in the GAMMA 10 tandem mirror

77

Plasma confinement in tokamaks with robust torus

78

Plasma confinement studies in LHD

79

Plasma control at JET

80

Plasma control issues for an advanced steady state tokamak reactor

81

Plasma control system for “Day-One” operation of KSTAR tokamak

82

Plasma control system upgrade and increased plasma stability in NSTX

83

Plasma control systems relevant to ITER and fusion power plants

84

Plasma convection in the Earth’s magnetosphere and ionosphere during substorms Original Research Article

85

Plasma convection in the low-latitude mantle of the near-earth magnetosphere Original Research Article

86

Plasma convection in the nightside magnetosphere of Saturn determined from energetic ion anisotropies

87

Plasma copolymer surfaces of acrylic acid/1,7 octadiene: Surface characterisation and the attachment of ROS 17/2.8 osteoblast-like cells

88

Plasma co-polymerized nano coatings – As a biodegradable solid carrier for tunable drug delivery applications

89

Plasma copper and lipid peroxidation in cigarette smokers

90

Plasma copper concentrations in pathological pregnancies

91

Plasma core for commercially feasible reactor

92

Plasma corticosterone and leptin concentration in male and female rats: debatable facts.

93

Plasma corticotropin levels in patients with familial amyloidotic polyneuropathy during liver transplantation

94

PLASMA CORTICOTROPINE RELEASING HORMONE (CRH) LEVEL DIFFERENCE BETWEEN WISTAR RATS EXPOSED TO ACUTE STRESS DUE TO PREDATOR AND TO THE PSYCHOLOGICAL STRESS DEVICE

95

Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test

96

Plasma corticotropin-releasing factor in depressive disorders

97

Plasma corticotropin-releasing hormone and unconjugated estriol in human pregnancy: Gestational patterns and ability to predict preterm delivery

98

Plasma cortisol in first episode drug-naïve mania: Differential levels in euphoric versus irritable mood

99

Plasma cortisol levels in response to a cold pressor test did not predict appetite or ad libitum test meal intake in obese women

100

Plasma Cotinine: Stability in Smokers and Validation of Self-Reported Smoke Exposure in Nonsmokers

101

Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients

102

Plasma C-reactive protein concentration is not affected by isocaloric dietary fat reduction

103

Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease

104

Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits

105

Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status

106

Plasma CRP-hs and Ferritin Concentration Related to Kidney Injury in Adult Patients with Beta-thalassemia: A Cross-sectional Study in Vietnam

107

Plasma current and position feedback control in ADITYA Tokamak

108

Plasma current profile diagnostics on FT-2 based on correlation reflectometry measurements of MHD modes

109

Plasma current sustainment after iron core saturation in the STOR-M tokamak

110

Plasma CVD of hard coatings Ti(CNO) using metallo-organic compound Ti(OC3H7)4

111

Plasma cystatin C determinations in a healthy elderly population

112

Plasma cystatin C: a better marker of glomerular filtration rate than creatinine in kidney transplantation

113

Plasma cystatin-C and development of coronary heart disease: The PRIME Study

114

Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction

115

Plasma cytokine levels in highly stressed children

116

Plasma cytokine levels in patients with severe burn injury-with reference to the relationship between infection and prognosis

117

Plasma cytokine levels: Relationship to early maternal interactions in socially reared vervet monkeys (Cercopithecus aethiops sabaeus)

118

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

119

Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia

120

Plasma Cytokines Profile in Subjects with Alzheimer’s Disease: Interleukin 1 Alpha as a Candidate for Target Therapy

121

Plasma cytokines, acute phase proteins and cortisol in major depression

122

Plasma D-Dimer as a Marker of Urinary Tract Infection in Children

123

Plasma D-dimer Concentration in Horses with Colic

124

Plasma D-Dimer Levels Correlated With Advanced Breast Carcinoma in Female Patients: A Prospective Study at Baghdad Teaching Hospital

125

Plasma decoloration of dye using dielectric barrier discharges with earthed spraying water electrodes

126

Plasma degradation of dyes in water with contact glow discharge electrolysis

127

Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia

128

Plasma densification of agglomerated Cr2O3 powder for thermal spray coating

129

Plasma density behavior with new graphite limiters in HT-7

130

Plasma density induced formation of nanocrystals in physical vapor deposited carbon films Original Research Article

131

‎Plasma density role on instability growth of transverse-longitudinal coupled electromagnetic modes in the collisional dense plasma

132

Plasma density variations observed on a satellite possibly related to seismicity Original Research Article

133

Plasma density-electric field turbulence in the low-latitude ionosphere from the observation on satellites; possible connection with seismicity

134

Plasma deoxycholic acid is related to deoxycholic acid in faecal water

135

Plasma deposited acrylic acid coatings: Surface characterization and attachment of 3T3 murine fibroblast cell lines

136

Plasma deposited coatings for biomedical materials and devices: Fluorocarbon and PEO-like coatings

137

Plasma deposition of acrylamide onto novel aromatic polyamide membrane for pervaporation

138

Plasma deposition of boron films with high growth rate and efficiency using carborane

139

Plasma deposition of hydrogenated diamond-like carbon films from CH4-Ar mixtures

140

Plasma deposition of La0.8Sr0.2MnO3 thin films on yttria-stabilized zirconia from aerosol precursor

141

Plasma deposition of organosilicon polymer thin films with embedded nanosilver for prevention of microbial adhesion

142

Plasma deposition of tetraethoxysilane on polycarbonate membrane for pervaporation of tetrafluoropropanol aqueous solution

143

Plasma Deposition of Thin Carbon Germanium Alloy Films from Organogermanium Compounds

144

Plasma deposition of thin film silicon: kinetics monitored by optical emission spectroscopy

145

Plasma deposition processes from acrylic/methane on natural fibres to control the kinetic release of lysozyme from PVOH monolayer film Original Research Article

146

Plasma derived versus biotechnological manufactured medicine

147

Plasma detection and control requirements for CO2 laser cutting

148

Plasma Dexamethasone Concentration and Cortisol Response during Manic Episodes

149

Plasma diagnosis by recognizing in situ data using a modular backpropagation network

150

Plasma diagnostic on a low-flow plasma for inductively coupled plasma optical emission spectrometry

151

Plasma diagnostic on a low-flow plasma for inductively coupled plasma optical emission spectrometry

152

Plasma diagnostical comparison of the MSIP process of (Ti,Al)N with pulsed and dc power supplies using energy-resolved mass spectroscopy

153

Plasma diagnostics and physics in the W7-AS stellarator

154

Plasma diagnostics and simulation for the SMART-1 mission

155

Plasma diagnostics as a tool for the modeling and simulation of sputter processes

156

Plasma diagnostics at Aditya Tokamak by two views visible light tomography

157

Plasma diagnostics by detecting the ion flux profile to a biased-target

158

Plasma diagnostics during laser ablation in a cavity

159

Plasma diagnostics for pulsed-dc plasma-polymerizing para-xylene using QMS and OES

160

Plasma diagnostics in a double inductively coupled source (DICP) for plasma sterilisation

161

Plasma diagnostics in a large helical device

162

Plasma Diagnostics in JFT-2M

163

Plasma diagnostics in pulsed laser deposition of GaLaS chalcogenides

164

Plasma diagnostics in the pulse magnetron sputtering system used for deposition Ti-C:H thin films

165

Plasma diagnostics of hybrid magnetron sputtering and pulsed laser deposition

166

Plasma diagnostics of pulsed d.c. glow discharge combined with ICP for deep nitriding process

167

Plasma diagnostics using millimetre wave two-dimensional imaging array

168

Plasma Diamine Oxidase Activities in Renal Dialysis Patients, a Human with Spontaneous Copper Deficiency and Marginally Copper Deficient Rats

169

Plasma diffusion and relaxation in a magnetic field

170

Plasma display panel with Ne+N/sub 2/ gas-mixture discharges

171

Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys

172

Plasma disposition and tissue depletion of chlortetracycline in the food producing animals, chickens for fattening

173

Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening

174

Plasma dissociation of H2S with O2 addition

175

Plasma distribution and SnO2 coating deposition using a rectangular filtered vacuum arc plasma source

176

Plasma distribution functions in plasmoids: GEOTAIL observations Original Research Article

177

Plasma distribution in the slender bore excited by coaxial rf electrode

178

Plasma D-lactate Levels in Necrotizing Enterocolitis in Premature Infants

179

Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours

180

Plasma DNA Concentration as an Early Predictor of Outcome in Critically-Ill Septic Patients

181

Plasma doping for the fabrication of ultra-shallow junctions

182

Plasma d-penicillamine redox state evaluation by capillary electrophoresis with laser-induced fluorescence

183

Plasma driven tritium uptake and leakage through plasma facing materials

184

Plasma dry etched p-silicon micromolds for permalloy microstructure array electrodeposition

185

Plasma dry reforming of methane in an atmospheric pressure AC gliding arc discharge: Co-generation of syngas and carbon nanomaterials

186

Plasma duplex treatment of stellite

187

Plasma dynamics and structural modifications induced by femtosecond laser pulses in quartz

188

Plasma dynamics as a key to successful upscaling of pulsed plasma processes

189

Plasma dynamics study by fast imaging and Sm1−xNdxNiO3 thin film deposition

190

Plasma edge cross-field transport: experiment and theory

191

Plasma edge fluid models for recycling at near tangential surfaces

192

Plasma effect in silicon charge coupled devices (CCDs)

193

Plasma effect in silicon charge coupled devices (CCDs)

194

Plasma effect in tape helix traveling-wave tube

195

Plasma effects for heavy ions in implanted silicon detectors

196

Plasma effects for heavy ions in implanted silicon detectors

197

Plasma elaboration of barrier layers: a study of the oxides formed at the surface of brass (90Cu10Zn) by RF electric discharges in oxygen

198

Plasma electrochemical growth of ion-conducting AgBr and AgCl

199

Plasma electrolyte oxidation of hydroxyapatite-containing coating on AZ31B Mg alloy: Effects of current density and duty cycle

200

Plasma Electrolyte, Protein and Metabolite Levels in Nigerian White Fulani Cattle under Two Different Management Systems

201

Plasma electrolytic deposition of titanium dioxide nanorods and nano-particles

202

Plasma electrolytic oxidation and corrosion protection of Zircaloy-4

203

Plasma electrolytic oxidation coating of synthetic Al–Mg binary alloys

204

Plasma electrolytic oxidation coating on AZ91 magnesium alloy modified by neodymium and its corrosion resistance

205

Plasma electrolytic oxidation of 2024-T3 aluminum alloy and investigation on microstructure and wear behavior

206

Plasma electrolytic oxidation of a zirconium alloy under AC conditions

207

Plasma electrolytic oxidation of aluminium networks to form a metal-cored ceramic composite hybrid material

208

Plasma electrolytic oxidation of AM60 magnesium alloy: Monitoring by acoustic emission technique. Electrochemical properties of coatings

209

Plasma electrolytic oxidation of titanium in heteropolytungstate acids

210

Plasma electrolytic surface carburizing and hardening of pure iron

211

Plasma Electron Capture Dissociation for the Characterization of Large Proteins by Top Down Mass Spectrometry

212

Plasma electron temperature diagnostics using semiconductor x-ray detector data analysed by a new theory on the x-ray responses

213

Plasma electron temperature variability in lunar surface potential and in electric field under average solar wind conditions Original Research Article

214

Plasma electrons in Saturnʹs magnetotail: Structure, distribution and energisation

215

Plasma electroplating Ni coating on pure copper sheet—the effects of H2SO4 concentration on the microstructure and mechanical properties

216

Plasma emission diagnostics for the transition from microcrystalline to amorphous silicon solar cells

217

Plasma emission mechanism for radio spikes from solar flares Original Research Article

218

Plasma endothelin and early coronary endothelial dysfunction in recipients of a cardiac transplant

219

Plasma endothelin is increased in early essential hypertension

220

Plasma endothelin levels in patients with cirrhosis

221

Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function

222

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

223

Plasma endothelin-1 and thrombomodulin levels in coronary sinus during right atrial pacing and percutaneous transluminal coronary angioplasty

224

Plasma endothelin-1 and tumor necrosis factor-α concentrations in pregnant and cyclic rats after low-dose endotoxin infusion, ,

225

Plasma endothelin-1 in patients with left-to-right shunt

226

Plasma endothelin-1 levels after coronary stenting in humans

227

Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms, ,

228

Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension

229

Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis

230

Plasma endothelin-I and total insulin exposure in diabetes mellitus

231

Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis

232

Plasma energy transport to an electrically biased surface

233

Plasma enhanced aerosol–gel deposition of Al2O3 coatings

234

Plasma enhanced atomic layer deposition of copper: A comparison of precursors

235

Plasma enhanced atomic layer deposition of magnesium oxide as a passivation layer for enhanced photoluminescence of ZnO nanowires

236

Plasma enhanced catalytic reforming of biomass tar model compound to syngas

237

Plasma enhanced chemical vapor deposition of low dielectric constant SiCFO thin films

238

Plasma enhanced chemical vapor deposition of silicon thin films for large area electronics

239

Plasma enhanced chemical vapor deposition of TiO2 films on silica gel powders at atmospheric pressure in a circulating fluidized bed reactor

240

Plasma enhanced chemical vapor deposition of ZnO thin films

241

Plasma enhanced chemical vapour deposition of BCxNy films prepared from N-trimethylborazine: Modelling, synthesis and characterization

242

Plasma enhanced chemical vapour deposition of silica onto titanium: Analysis of surface chemistry, morphology and hydroxylation

243

Plasma enhanced chemical vapour deposition of SiO N in an x y integrated distributed electron cyclotron resonance reactor

244

Plasma enhanced CVD deposition of titanium oxide for biomedical applications

245

Plasma enhanced CVD of fluorocarbon films by low-pressure dielectric barrier discharge

246

Plasma enhanced CVD of SiOxCyHz thin film on different textile fabrics: Influence of exposure time on the abrasion resistance and mechanical properties

247

Plasma enhanced growth of single walled carbon nanotubes at low temperature: A reactive molecular dynamics simulation Original Research Article

248

Plasma enhanced magnetron sputter deposition of Ti–Si–C–N based nanocomposite coatings

249

Plasma enhanced surface treatments using electron beam-generated plasmas

250

Plasma enhanced-CVD of undoped and fluorine-doped Co3O4 nanosystems for novel gas sensors

251

Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions

252

Plasma environment of a weak comet – Predictions for Comet 67P/Churyumov–Gerasimenko from multifluid-MHD and Hybrid models

253

Plasma environment of comet Wirtanen during its low-activity stage

254

Plasma environment of Jupiter family comets

255

Plasma enzymatic, biochemical and hormonal responses to clove oil, 2-phenoxy ethanol, and MS-222 exposed to Caspian brown trout (Salmo trutta caspius, kessleri)

256

Plasma Equilibrium in Tokamaks

257

Plasma erosion in the Venus nightside ionosphere Original Research Article

258

Plasma esterase activities in young and old patients undergoing open inguinal hernia repair

259

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography–mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Original Research Article

260

Plasma estrone sulphate (E1S) and estradiol-17β (E2β) profiles during pregnancy and their relationship with the relaxation of sacrosciatic ligament, and prediction of calving time in Holstein–Friesian cattle

261

Plasma etching and feature evolution of organic low-k material by using VicAddress Original Research Article

262

Plasma etching and plasma physics experiments for the undergraduate microelectronics course

263

Plasma etching of As2S3 films for optical waveguides

264

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

265

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

266

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

267

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

268

Plasma etching: principles, mechanisms, application to micro- and nano-technologies

269

Plasma Evolutions Around a Solar Coronal 3D Magnetic Null Point

270

Plasma exchange and hemodialysis for severe manifestations of multiple wasp stings in a child

271

Plasma exchange in Goodpasture syndrome associated with Turner’s syndrome: A case report

272

Plasma exchange in Kawasaki disease

273

PLASMA EXCHANGE IN PATIENTS WITH THE DIAGNOSIS OF GUILLAIN-BARRE SYNDROME: AN EXPERIENCE IN INTENSIVE CARE UNIT

274

Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature

275

Plasma experiments with relevance for the nonlinear behavior of semiconductors

276

Plasma extraction in a capillary-driven microfluidic device using surfactant-added poly(dimethylsiloxane)

277

Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age

278

Plasma facing and high heat flux materials – needs for ITER and beyond

279

Plasma facing components of EAST

280

Plasma fatty acid changes in rats after long term fructose diet administration

281

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

282

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

283

Plasma fatty acid status in Moroccan children: increased lipid peroxidation and impaired polyunsaturated fatty acid metabolism in protein-calorie malnutrition

284

Plasma fatty acids concentrations in postoperative patients with biliary atresia

285

Plasma fatty-acid composition and antioxidant capacity in low birth-weight infants fed formula enriched with n−6 and n−3 long-chain polyunsaturated fatty acids from purified phospholipids

286

Plasma feedback controller reorganisation for ASDEX Upgradeʹs new discharge control and data acquisition system

287

Plasma ferritin and pregnancy outcome, , ,

288

Plasma ferritin, premature rupture of membranes, and pregnancy outcome, , ,

289

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience

290

Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm

291

Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina

292

Plasma fibrinogen concentration in a Chinese population

293

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

294

PLASMA FIBRINOGEN LEVEL IN DIABETICS WITH COMPLICATIONS – A PROSPECTIVE STUDY

295

Plasma fibronectin in French centenarians

296

Plasma Fibronectin in Saliva of Women with History of Miscarriage(s) and Periodontal Disease - a Pilot Study

297

Plasma fibronectin levels in ischemic heart disease

298

Plasma flow across the cusp-magnetosheath boundary under northward IMF Original Research Article

299

Plasma flow measurement in high- and low-field-side SOL and influence on the divertor plasma in JT-60U

300

Plasma flow over an array of particles

301

Plasma flow simulation in an off-plane double bend magnetic filter

302

Plasma flow variations and energetic protons upstream of the earth’s bow shock: A statistical study Original Research Article

303

Plasma flow velocity measurements using a modulated Michelson interferometer

304

Plasma Fluoride Level and Femoral Bone Mineral Density in Post-Menopausal Women

305

Plasma focus assisted damage studies on tungsten

306

Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study

307

Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility

308

Plasma Fractionation in Malaysia

309

Plasma Fractionation Industry Project in Turkey: Country’s Experiences

310

Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine

311

Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet

312

Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study

313

Plasma Free Fatty Acids and Risk of Atrial Fibrillation (from the Cardiovascular Health Study)

314

Plasma free iron and chemotherapy toxicity

315

Plasma frequency approach to estimate the Debye temperature of the ionic crystals and metal alloys Original Research Article

316

Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes

317

Plasma from preeclamptic women increases human endotheial cell prostacyclin production without changes in cellular enzyme activity or mass,

318

Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein

319

Plasma fullerene production from powdered carbon black Original Research Article

320

Plasma functionalization for improving dispersion and interfacial bonding of multi-wall carbon nanotubes in cyanate ester/epoxy nanocomposites

321

Plasma functionalization of polypropylene with acrylic acid

322

Plasma functionalization of silicon carbide crystalline nanoparticles in a novel low pressure powder reactor

323

Plasma functionalization of titanium surface for repulsion of blood platelets

324

Plasma GABA in children and adolescents with mood and behavior diorders

325

Plasma GABA predicts acute response to divalproex in mania

326

Plasma GABA predicts response to divalproex in mania

327

Plasma gasification of sewage sludge: Process development and energy optimization

328

Plasma gasification process: Modeling, simulation and comparison with conventional air gasification

329

Plasma generation of supported metal catalysts Original Research Article

330

Plasma Ghrelin Concentration and Obesity: The Effect of Smoked Drugs

331

Plasma ghrelin level in children with type 1 diabetes mellitus

332

Plasma Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Response to Liquid Phase, Solid Phase, and Meals of Differing Lipid Composition

333

Plasma Glucose Alone Does Not Predict Neurologic Dysfunction in Hypoglycemic Nondiabetic Subjects, ,

334

PLASMA GLUCOSE CONCENTRATION AND LIPID PROFILE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS TREATED WITH EXTRACTS OF TRIPLOCHITON SCLEROXYLON K. SCHUM.

335

Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: A peripheral α-2 adrenoceptor antagonist

336

Plasma glucose, lactate, sodium, and potassium levels in children hospitalized with acute alcohol intoxication

337

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

338

Plasma glutamine response to enteral administration of glutamine in human volunteers (free glutamine versus protein-bound glutamine)

339

Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity

340

Plasma glutathione S-transferase Alpha 1-1: A more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy, , , ,

341

Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose

342

Plasma Glycosaminoglycans: A new Promising tool for Assessment of Non-Metastatic Renal Cell Carcinoma Patients Following Nephrectomy

343

Plasma gonadotropins and ovarian hormones during the estrous cycle in high compared to low ovulation rate gilts

344

Plasma gossypol dynamics in white-tailed deer: Implications for whole cottonseed as a supplemental feed

345

Plasma grafting montmorillonite/iron oxide composite with β-cyclodextrin and its application for high-efficient decontamination of U(VI)

346

Plasma granulysin concentrations and preeclampsia risk

347

Plasma grid design for optimized filter field configuration for the NBI test facility ELISE

348

Plasma Growth Hormone and Prolactin Levels in Healthy Sedentary Young Men after Short-Term Endurance Training under Hot Environment

349

Plasma heating and current drive systems for the fusion ignition research experiment (FIRE)

350

Plasma Heating by Neutral Beam Injection

351

Plasma heating in the initial phase of solar flares

352

Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province, China

353

Plasma high sensitivity C-reactive protein as a marker of severity in children with diabetic ketoacidosis

354

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

355

Plasma homocyst(e)ine, folate and vitamin B12 levels among school children in Taiwan: The Taipei Children Heart Study

356

Plasma homocysteine and all-cause mortality in diabetes

357

Plasma homocysteine and cardiovascular disease mortality

358

Plasma homocysteine and cardiovascular risk factors in African American women

359

Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus

360

Plasma homocysteine and heart disease

361

Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study

362

Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals: The Hoorn Study

363

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease

364

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

365

Plasma homocysteine concentration and blood pressure in young adult African Americans

366

Plasma homocysteine concentration is decreased by dietary intervention

367

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation, ,

368

Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects

369

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men Original Research Article

370

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism

371

Plasma homocysteine concentrations do not influence craving in alcohol withdrawal

372

Plasma homocysteine concentrations in a Belgian school-age population

373

Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal

374

PLASMA HOMOCYSTEINE CONCENTRATIONS IN YOUNG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

375

Plasma homocysteine in 80-year-olds: Relationships to medical, psychological and social variables

376

Plasma homocysteine in families of type 1 diabetic patients

377

Plasma homocysteine in subjects with familial combined hyperlipidemia

378

Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients

379

Plasma Homocysteine Is Not Involved in the Thrombotic Risk of (beta)Thalassemia major Patients

380

Plasma Homocysteine Level and Coronary Artery Disease in Type 2 Diabetic Patients without Nephropathy

381

Plasma Homocysteine Level and Its Genotypes as a Risk Factor for Coronary Artery Disease in Patients Undergoing Coronary Angiography

382

Plasma Homocysteine Level and its Relationship to Clinical Profile in Parkinson’s Disease Patients at the Lagos University Teaching Hospital

383

Plasma homocysteine level and the course of ischemic stroke

384

Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score

385

Plasma Homocysteine Level in Patients with Behcet’s Disease with or without Thrombosis

386

Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study

387

Plasma homocysteine levels and heart disease

388

Plasma homocysteine levels and heart disease

389

Plasma homocysteine levels and late outcome after coronary angioplasty

390

Plasma homocysteine levels in cardiovascular disease, malaria and protein–energy malnutrition in Sudan

391

Plasma homocysteine levels in cycling, pregnant, and spayed bitches

392

Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper

393

Plasma homocysteine levels in patients with isolated coronary artery ectasia

394

Plasma Homocysteine Measurement with Ion Exchange Chromatography (Jeol Aminotac 500): A Comparison with the Abbott IMx Assay

395

Plasma homocysteine predicts progression of atherosclerosis

396

Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia

397

Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women

398

Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal

399

Plasma homovanillic acid concentrations in catatonia

400

Plasma homovanillic acid in the prodromal phase of schizophrenia

401

Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex

402

Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: Comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance

403

Plasma homovanillic acid profile at different phases of the ovulatory cycle in healthy women

404

Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling

405

Plasma hydrophilic surface treatment for dehumidifying heat exchangers

406

Plasma hydroxyurea determined by gas chromatography–mass spectrometry

407

Plasma IGF-2 Concentration and Tissue Expression in Dogs with Malignant Mammary Tumor

408

Plasma IGF-I levels and cognitive performance in older women

409

Plasma IL-10 Concentration and Its Role in the Pathogenesis of Acute Myeloid Leukemia: a Prospective Study

410

Plasma imaging and spectroscopy diagnostics developed on 100-500-kA pulsed power devices

411

Plasma immersion ion implantation based on glow discharge with electrostatic confinement of electrons

412

Plasma immersion ion implantation experiments at the Instituto Nacional de Pesquisas Espaciais (INPE), Brazil

413

Plasma immersion ion implantation experiments with long and short rise time pulses using high voltage hard tube pulser

414

Plasma immersion ion implantation for shallow junctions in silicon

415

Plasma immersion ion implantation in arc and glow discharge plasmas submitted to low magnetic fields

416

Plasma immersion ion implantation induced improvements of mechanical properties, wear resistance, and adhesion of diamond-like carbon films deposited on tool steel

417

Plasma immersion ion implantation into cylindrical bore using internal inductively-coupled radio-frequency discharge

418

Plasma immersion ion implantation of cold-work steel

419

Plasma immersion ion implantation of complex-shaped objects: an experimental study on the treatment homogeneity

420

Plasma immersion ion implantation of cylindrical bore using self-excited radio-frequency glow discharge

421

Plasma immersion ion implantation of industrial gears

422

Plasma immersion ion implantation of insulating materials

423

Plasma immersion ion implantation of nitrogen in Si: formation of SiO2, Si3N4 and stressed layers under thermal and sputtering effects

424

Plasma immersion ion implantation of nitrogen on austenitic stainless steel at variable energy for enhanced corrosion resistance

425

Plasma immersion ion implantation of poly(tetrafluoroethylene)

426

Plasma immersion ion implantation of polymers and silver–polymer nano composites

427

Plasma immersion ion implantation of TiAl using chlorine containing plasma

428

Plasma immersion ion implantation treatment of medical implants

429

Plasma immersion ion implantation using polymeric substrates with a sacrificial conductive surface layer

430

Plasma immersion ion implantation using titanium and oxygen ions

431

Plasma immersion ion implantation—a fledgling technique for semiconductor processing

432

Plasma immersion ion implanted Ti–B-based coatings: Tribological behaviour at room and high temperatures

433

Plasma immersion low-energy-ion bombardment of naked DNA

434

Plasma immersion N and N+C implantation into high-speed tool steel: surface morphology, phase composition and mechanical properties

435

Plasma immersion nitrogen implantation into silicon and rapid thermal electron beam annealing for surface structuring

436

Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome

437

Plasma immunoreactive endothelin-1 levels in hypertensive rats and human subjects

438

Plasma impurity content, gas fueling, and exhaust on DIII-D over extended periods between boronizations

439

Plasma in a high-frequency electric field with a reflective condition on the boundary

440

Plasma in Saturnʹs nightside magnetosphere and the implications for global circulation

441

Plasma inactivation of Escherichia coli cells by atmospheric pressure air brush-shape plasma

442

Plasma induced effects within the bulk material of wood veneers

443

Plasma induced grafting of PSt onto titanium dioxide powder. II

444

Plasma induced patterning of polydimethylsiloxane surfaces

445

Plasma induced sp2 to sp3 transition in boron nitride

446

Plasma Influence of Surface Texture of Silicone Rubber for Biomedical Application in Scala Tympani

447

Plasma Inorganic Iodine and Thyroxine Concentrations for Beef Cows in Late Pregnancy and Early Lactation Associated with Different Levels of Dietary Iodine Supplementation

448

Plasma Insulin and Carotid Intima Media Thickness in Hypertensive and Non Hypertensive Type 2 Diabetics

449

Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice

450

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men

451

Plasma Insulin-like Growth Factor 1 Distribution and Its Relation to Blood Pressure in Adolescents : The Bogalusa Heart Study

452

Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside

453

Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure

454

Plasma interaction processes during the pulsed laser deposition of superconducting thin films

455

Plasma interaction with liquid lithium: Measurements of retention and erosion

456

Plasma interactions of exoplanets with their parent star and associated radio emissions

457

Plasma interactions with the outboard chamber wall in DIII-D

458

PLASMA INTERFERENCE IN AN ENZYME-LINKED IMMUNOSORBANT ASSAY USING A COMMERCIAL MATCHED ANTIBODY PAIR

459

Plasma interferometry and how the bound-electron contribution can bend fringes in unexpected ways

460

Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6

461

Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

462

Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders

463

Plasma interleukin-2 levels and thyroid function in elderly patients with nonthyroidal illness

464

Plasma interleukin-22 and its cellular receptor (IL-22RA1) expression in chronic lymphocytic leukemia

465

Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis Original Research Article

466

Plasma interleukin-6 is associated with psychological coronary risk factors: Moderation by use of multivitamin supplements

467

Plasma intrusion above Mars crustal fields—Mars Express ASPERA-3 observations

468

Plasma ion composition measurements for Europa

469

Plasma Iron Indices in Pregnant Women Referred to the University of Abuja Teaching Hospital, Nigeria

470

Plasma iron is associated with lipid peroxidation in an elderly population

471

PLASMA IRON IS ASSOCIATED WITH LIPID PEROXIDATION IN WOMEN

472

Plasma irradiation effects in phthalocyanine films

473

Plasma jet imaging by CCD technology in rapid mold manufacturing

474

Plasma jet impacts on Citrinin production in isolates belonging to Penicillium Spp.

475

Plasma jet treatment of five polymers at atmospheric pressure: surface modifications and the relevance for adhesion

476

Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease

477

Plasma l-arginine is markedly reduced in pregnant women affected by preeclampsia

478

Plasma LDL subtype distribution in patients with or without coronary stenosis

479

Plasma lens experiment at the final focus test beam

480

Plasma lens experiment at the final focus test beam

481

Plasma lens focusing and plasma channel transport for heavy ion fusion

482

Plasma lens formation in eγ and γγ colliders

483

Plasma leptin and adiponectin concentrations in postmenopausal women with breast cancer following aerobic exercise

484

Plasma Leptin and its Relationship with Lipid Peroxidation and Nitric Oxide in Obese Female Patients with or without Hypertension

485

Plasma leptin and prognosis in patients with established coronary atherosclerosis Original Research Article

486

Plasma Leptin Concentration in Cord Blood: Relationship to the Degree of Preeclampsia and Placental Weight

487

Plasma leptin concentration in migraine; the relationship with orexinergic nerve function

488

Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry

489

Plasma leptin concentrations during the reproductive cycle in the native Thai chicken (Gallus domesticus)

490

Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training

491

PLASMA LEPTIN CONCENTRATIONS IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY (ROP)

492

Plasma leptin in growing lambs as a potential predictor for carcass composition and daily gain

493

Plasma leptin levels and inflammation biomarkers in well nourished and malnourished haemodialysed patients

494

Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters

495

Plasma leptin levels in patients with burn injury: a preliminary report

496

Plasma leptin, ghrelin and adiponectin concentrations in young fit racehorses versus mature unfit standardbreds

497

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

498

Plasma Level Monitoring of Oxcarbazepine in Epileptic Patients

499

Plasma level of adhesion molecules in patients suffering from stable and unstable angina

500

Plasma Level of Antioxidant Vitamins and Lipid Peroxidation in Breast Cancer Patients

501

Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance

502

Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma

503

Plasma Level of miRNA7, miRNA409 and miRNA93 as Potential Biomarkers for Colorectal Cancer

504

Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus

505

Plasma Level of Oxidized Low- Density Lipoprotein in Macroalbuminuric Type 2 Diabetic Patients versus Normoalbuminuric Group

506

Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin Original Research Article

507

Plasma level of trace elements in patients with oral lichen planus

508

Plasma level of vitamin C in women with pre-eclampsia in Ardabil, Iran

509

Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure

510

Plasma levels and profiles of dioxin and dioxin-like compounds in Ontario Great Lakes anglers

511

Plasma levels of 15-F2t-isoprostane in newborn infants are affected by mode of delivery

512

Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s disease

513

Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy

514

Plasma levels of a low-dose constant-rate-infusion of ketamine and its effect on single and repeated nociceptive stimuli in conscious dogs

515

Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy

516

Plasma levels of adrenomedullin in patients with mitral stenosis, , ,

517

Plasma Levels of Adrenomedullin in Primary and Secondary Pulmonary Hypertension in Patients <20 Years of Age

518

Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease

519

Plasma Levels of Anabolic Hormones in Suckling Lambs are Affected by Late Gestational Nutrition

520

Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: An epidemiological study

521

Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity

522

Plasma levels of atrial natriuretic peptide in severe burn injury

523

Plasma levels of beta-amyloid (1–42) in Alzheimerʹs disease and mild cognitive impairment

524

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis, ,

525

Plasma Levels of Brain Natriuretic Peptide in Children With Left-To-Right Shunt Before and After Cardiac Surgery

526

Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise

527

Plasma levels of chemokines during leprosy specific treatment

528

Plasma levels of copper, manganese and selenium in an adult population in southern Spain: Influence of age, obesity and lifestyle factors Original Research Article

529

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

530

Plasma levels of DDT and their association with reproductive hormones in adult men from northern Thailand

531

Plasma levels of endothelin-1 and thrombomodulin in burn patients

532

Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure

533

Plasma levels of fibrinogen as a pathogenic factor or risk indicator of atherosclerosis

534

Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity

535

Plasma levels of heat shock protein 72 (HSP72) and β-endorphin as indicators of stress, pain and prognosis in horses with colic

536

Plasma Levels of IFN-γ, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis

537

Plasma levels of IL-6 and TNF-α in patients with esophageal cancer

538

Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment

539

Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease

540

Plasma levels of interlukin-4 and Interferon- in patients with chronic or healed cutaneous leishmaniasis

541

Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?

542

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

543

Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits

544

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

545

Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers

546

Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris

547

Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis

548

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome

549

Plasma levels of miR-29a and miR-146a in relation to carotid intima media thickness measurement for detection of carotid atherosclerosis

550

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease

551

Plasma levels of N-telopeptide of Type I collagen in periodontal health, disease and after treatment

552

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

553

Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques

554

Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion

555

Plasma levels of resistin-like molecule beta in humans

556

Plasma levels of sex steroids (testosterone, progesterone and 17β-estradiol) in Rohu Carp Labeo rohita broodstock from Khuzestan, Iran

557

Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia

558

Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha

559

Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease Original Research Article

560

Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission

561

Plasma Levels of Soluble Tumor Necrosis Factor Receptor Type I During the Acute Phase Following Complicated Myocardial Infarction Predicts Survival in High-Risk Patients Original Research Article

562

Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity

563

Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians

564

Plasma Levels of the Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 are Elevated in Patients with Acute Myocardial Infarction

565

Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects

566

Plasma levels of thrombomodulin in pulmonary hypertension

567

Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Correlated With the Presence of Transplant Coronary Artery Disease in Cardiac Transplant Recipients

568

Plasma Levels of Troponin T After Electrical Cardioversion of Atrial Fibrillation and Flutter

569

Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns

570

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt1, in haematological cancers: A comparison with breast cancer

571

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

572

Plasma levels of vascular endothelial growth factor and its soluble receptor in non-alcoholic fatty liver disease

573

Plasma Levels of Vascular Endothelial Markers in Obstructive Sleep Apnea

574

Plasma Levels of Viro-Immunological Markers in HIV-Infected and Noninfected Ethiopians: Correlation with Cell Surface Activation Markers

575

Plasma levels of vitamin E in Parkinsonʹs disease

576

Plasma levels of vitellogenin and eggshell zona radiata proteins in 4-nonylphenol and o,p′-DDT treated juvenile Atlantic salmon (Salmo salar)

577

Plasma levels of β-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine

578

Plasma LH concentrations after administration of human chorionic gonadotropin to estrous mares

579

Plasma Liner with an Intermediate Heavy Shell and Thermal Pressure Drive

580

Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension

581

Plasma lipid changes after supplementation with (beta)-glucan fiber from yeast

582

Plasma lipid levels in Alzheimer’s disease patients treated by Donepezil hydrochloride: a cross-sectional study

583

Plasma lipid levels in patients with acute bacterial infections

584

Plasma Lipid Levels in Patients with Cataract, with and without Pseudoexfoliation Syndrome

585

Plasma lipid modifications in elderly people after administration of two virgin olive oils of the same variety (Olea europaea var. hojiblanca) with different triacylglycerol composition

586

Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease

587

Plasma lipid pattern and red cell membrane structure in β-thalassemia patients in Jakarta

588

Plasma Lipid Peroxidation and Total Antioxidant Status among Dyslipidaemic and Hypertensive Nigerians with High Risk of Coronary Heart Disease

589

Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients

590

Plasma Lipid Profile in Non-Diabetic Rats Treated with Extracts of Triplochiton Scleroxylon K. Schum

591

Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan — a unique experience Original Research Article

592

Plasma lipid regulatory effect of compounded freshwater clam hydrolysate and Gracilaria insoluble dietary fibre

593

Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment

594

Plasma lipids and apolipoproteins in a population of Orang Asli (‘aboriginesʹ) from West Malaysia

595

Plasma lipids and cardiovascular risk: a POSCH report

596

Plasma lipids and their role in disease, Edited by Philip J. Barter and Kerry-Anne Rye, Harwood Academic Publishers, 1999. ISBN: 90-5702-466-7; US$120

597

Plasma lipids are altered in Gaucher disease: Biochemical markers to evaluate therapeutic intervention

598

Plasma lipids relationship with results of Oral Glucose Challenge Test in pregnancy

599

Plasma lipids, clotting factors and cardiovascular risk

600

Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity

601

Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease re sulting from alcohol abuse: effects of alcohol intake cessa tion : Camps J.; Pizarro, I.; Prats, E.; La Ville A.; Turner, P. R.; Masana, L.; Joven, J. J. Hepatol. 20:7

602

Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia

603

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin Original Research Article

604

Plasma lipoprotein fatty acids are altered by the positional distribution of fatty acids in infant formula triacyiglycerols and human milk

605

Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis

606

Plasma lipoprotein responses to enzyme-replacement in Gaucherʹs disease

607

Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

608

Plasma Lipoprotein-associated Phospholipase A2 Is Inversely Correlated with Proprotein Convertase Subtilisin-kexin Type 9

609

Plasma Lipoproteins and Atherosclerosis: Accomplishments and Opportunities

610

Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women

611

Plasma low-density lipoprotein immobilized silica as stationary phase in nano-liquid chromatography

612

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study

613

Plasma Malondialdehyde and Obesity: Is there a Relationship?

614

Plasma malondialdehyde is induced by smoking: a study with balanced antioxidant profiles

615

Plasma mannan-binding lectin kills microorganisms

616

Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats

617

Plasma maser effect in magnetosphere plasma associated with MHD turbulence

618

Plasma material interaction studies on low activation materials used for plasma facing or blanket component

619

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

620

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

621

Plasma melatonin and cortisol in patients with obsessive–compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms

622

Plasma melting and useful application of molten slag

623

Plasma membrane cholesterol plays a critical role in the Salmonella-induced anti-inflammatory response in intestinal epithelial cells

624

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

625

Plasma Membrane Depolarization Induced by Abscisic Acid in Arabidopsis Suspension Cells Involves Reduction of Proton Pumping in Addition to Anion Channel Activation, Which Are Both Ca2+ Dependent

626

Plasma membrane depolarization reduces nitric oxide (NO) production in P388D.1 macrophage-like cells during Leishmania major infection

627

Plasma membrane depolarization-activated calcium channels, stimulated by microtubule-depolmerizing drugs in wild-type Arabidopsis thaliana protoplasts, display constitutively large activities and a longer half-life in ton 2 mutant cells affected in the or

628

Plasma membrane functionalization using highly fusogenic immune activator liposomes

629

Plasma membrane H+-ATPase, succinate and isocitrate dehydrogenases activities of vessel-associated cells in walnut trees

630

Plasma membrane ion channels in suicidal cell death

631

Plasma Membrane Is the Primary Site of Localization of the Nonactivated Estrogen Receptor in the Goat Uterus: Hormone Binding Causes Receptor Internalization

632

Plasma membrane lipid alterations induced by cold acclimation and abscisic acid treatment of winter wheat seedlings differing in frost resistance

633

Plasma membrane NADH oxidase is gravi-responsive

634

Plasma membrane NADH oxidase of maize roots responds to gravity and imposed centrifugal forces

635

Plasma membrane permeabilization by trains of ultrashort electric pulses

636

Plasma Membrane Receptors for Exopolysaccharides of the Ring Rot Causal Agent in Potato Cells

637

Plasma Membrane Redox System in the Erythrocytes of Rowers: Pilot Study

638

Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes

639

Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography

640

Plasma membrane segregation during T cell activation: probing the order of domains

641

Plasma membrane transport in context — making sense out of complexity

642

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

643

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

644

Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age

645

Plasma Membrane-porating Domain in Poliovirus 2B Protein. A Short Peptide Mimics Viroporin Activity

646

Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency

647

Plasma metabolites and nitrogen balance in Lama glama associated with forage quality at altitude

648

Plasma Metalloproteinase-12 and Tissue Inhibitor of Metalloproteinase-1 Levels and Presence, Severity, and Outcome of Coronary Artery Disease

649

Plasma met-enkephalin levels: its relationship with age and type of headache

650

Plasma met-enkephalin, β-endorphin and leu-enkephalin levels in human hepatic encephalopathy

651

Plasma methane conversion in the presence of carbon dioxide using dielectric-barrier discharges

652

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia Original Research Article

653

Plasma microcirculation in alveolar capillaries: Effect of parachute-shaped red cells on gas exchange

654

Plasma microRNA profiles for bladder cancer detection

655

Plasma microRNA profiles for bladder cancer detection

656

Plasma microRNAs as non-invasive biomarkers in bovine endometritis caused by Gram-negative and Gram-positive bacteria

657

Plasma mixing as a cause of solar wind magnetic field variations Original Research Article

658

Plasma modeling for position and current control in FTU

659

Plasma modelisation and control for laser dismantling

660

Plasma modelling of matrix assisted UV laser desorption ionisation (MALDI)

661

Plasma Modes of Low-Dimensional Electron Systems over a Helium Film

662

Plasma modification of polycarbonates

663

Plasma modification of polylactic acid in a medium pressure DBD

664

Plasma modification of polypropylene surfaces and its alloying with styrene in situ

665

Plasma modification of self-assembled structures of CoTMPP molecules

666

Plasma modifications of porous PEEK–WC–PU membranes Original Research Article

667

Plasma modified polymers as a support for enzyme immobilization 1.: Allyl alcohol plasma

668

Plasma modified polymers as a support for enzyme immobilization II. Amines plasma

669

Plasma molding over surface topography: Simulation and measurement of ion fluxes, energies and angular distributions over trenches in RF high density plasmas

670

Plasma molybdenum reflects dietary molybdenum intake

671

Plasma multivariable robust control system design and simulation for a thermonuclear tokamak-reactor

672

Plasma Myeloperoxidase Activity and Apolipoprotein A-1 Expression in Chronic Hepatitis B Patients

673

Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure

674

Plasma n-3 and n-6 polyunsaturated fatty acids association with blood pressure level in healthy males

675

Plasma nanostructuring of porous polymer membranes

676

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

677

Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction

678

Plasma Nesfatin-1 and Insulin Resistance Changes Immediately After Circuit-Resistance Exercise and During Recovery Periods in Healthy Men

679

Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals

680

Plasma neuropeptide Y and total- and LDL-cholesterol are closely correlated in women without evident relation to the metabolic syndrome.

681

Plasma Neuropeptide Y Concentrations in Combat Exposed Veterans: Relationship to Trauma Exposure, Recovery from PTSD, and Coping

682

Plasma neuropeptide-Y concentrations in humans exposed to military survival training

683

Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients

684

Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients

685

Plasma Neutrophil Gelatinase Associated Lipocalin in Neonates With and Without Sepsis

686

Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery

687

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker for Prediction of 3-Month Graft Survival after Kidney Transplantation

688

Plasma Neutrophil Gelatinase–Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults: The Rancho Bernardo Study

689

Plasma Niobium Surface Alloying of Pure Titanium and its Oxidation at 900 °C

690

Plasma Nitric Oxide and Acute Phase Proteins after Moderate and Prolonged Exercises

691

Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain

692

Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction

693

Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia

694

Plasma nitridation of a novel Ni–10.8 wt.%Cr nanocomposite Original Research Article

695

Plasma nitridation of aluminized high purity iron

696

Plasma nitridation of aluminized high purity iron Original Research Article

697

Plasma nitridation of Ge(100) surface studied by scanning tunneling microscopy

698

Plasma nitrided and TiCN coated AISI H13 steel by pulsed dc PECVD and its application for hot-working dies

699

Plasma nitrided austenitic stainless steels for automotive hydrogen applications

700

Plasma nitriding and in situ characterisation of aluminium

701

Plasma nitriding and nitrocarburising of sintered FeCrMo and FeCrMoC alloys

702

Plasma Nitriding Behavior of DIN 1.2344 Hot Work Tool Steel

703

Plasma nitriding behavior of low carbon binary alloy steels

704

Plasma nitriding behavior of Ti6Al4V orthopedic alloy

705

Plasma nitriding of 316L austenitic stainless steel: Experimental investigation of fatigue life and surface evolution

706

Plasma nitriding of 42CrMo low alloy steels at anodic or cathodic potentials

707

Plasma nitriding of 90CrMoV8 tool steel for the enhancement of hardness and corrosion resistance

708

Plasma nitriding of AISI 304 austenitic stainless steel with pre-shot peening

709

Plasma nitriding of AISI 304 stainless steel: Role of surface mechanical attrition treatment

710

Plasma nitriding of AISI 316L austenitic stainless steels at anodic potential

711

Plasma nitriding of Al alloys by DC glow discharge

712

Plasma nitriding of austenitic stainless steel in N2 and N2–H2 dc pulsed discharge

713

Plasma nitriding of Fe-Cr-Mo sintered steels

714

Plasma nitriding of Fe-Cr-Mo sintered steels

715

Plasma nitriding of low alloy steels at floating and cathodic potentials

716

Plasma nitriding of plastic mold steel to increase wear- and corrosion properties

717

Plasma nitriding of sintered AISI 316L at several temperatures

718

Plasma nitriding of Ti6Al4V alloy and AISI M2 steel substrates using D.C. glow discharges under a triode configuration

719

Plasma nitriding to selective laser sintering parts made of SCM430 powder

720

Plasma nitriding using high H2 content gas mixtures for a cavitation erosion resistant steel

721

Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans

722

Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals

723

Plasma nitrite reserve and endothelial function in the human forearm circulation

724

Plasma nitrites as an indicator of nitric oxide production: Unchanged production or reduced renal clearance in preeclampsia?

725

Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction Original Research Article

726

Plasma nitrosulfurizing techniques for low friction coefficient with H2S and C3H8 gas addition

727

Plasma non-cholesterol sterols

728

Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder

729

Plasma norepinephrine and prediction of outcome in major depressive disorder

730

Plasma norepinephrine kinetics in patients with posttraumatic stress disorder

731

Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagasʹ heart disease

732

Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression

733

Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Origin

734

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction

735

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea

736

Plasma N-terminal pro-brain natriuretic peptide level as a marker of adverse outcome in patients with co-existing diabetes, chronic kidney disease and heart failure

737

Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention

738

Plasma N-Terminal Prohormone Brain Natriuretic Peptide as a Marker for Postoperative Cardiac Events in High-Risk Patients Undergoing Noncardiac Surgery

739

Plasma NT-PRO BNP concentrations are associated with ambulatory blood pressure in black hypertensive patients with normal systolic function on echocardiography

740

Plasma NT-pro BNP Concentrations in Patients with Hypertensive Chronic Kidney Disease

741

Plasma Obestatin Concentrations Are Negatively Correlated with Body Mass Index, Insulin Resistance Index, and Plasma Leptin Concentrations in Obesity and Anorexia Nervosa

742

Plasma obestatin, estradiol, and liver ATP concentrations in response to endurance exercise training at different durations in male rats

743

Plasma oestradiol and progesterone during early pregnancy in the cow and the effects of treatment with buserelin

744

Plasma oestrogen and the regulation of egg weight in laying hens by dietary fats

745

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking

746

Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans

747

Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension

748

Plasma operation and control

749

Plasma operation with tungsten tiles at the central column of ASDEX Upgrade

750

Plasma optical emission spectroscopy diagnostic during amorphous silicon thin films deposition by Rf sputtering technique

751

Plasma oscillations in nanotubes and the Aharonov-Bohm effect for plasmons

752

Plasma osmolality in acute spontanious intra-cerebral hemorrhage: Does it influence hematoma volume and clinical outcome?

753

Plasma Osteopontin and Interleukin-18 Levels in Patients with Systemic Lupus Erythematosus: Association with Disease Activity and Lupus Nephritis

754

Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma

755

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease

756

Plasma Osteopontin Levels Are Higher in Patients With Primary Aldosteronism Than in Patients With Essential Hypertension

757

Plasma over-treatment effect on the MOCVD-TiN contact glue layer

758

Plasma oxidation of bilayered Y/Zr films

759

Plasma oxidation of the insulation layer in the magnetic tunneling junctions

760

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

761

Plasma oxynitrocarburizing of 40Cr steel in an atmosphere of gasoline and air

762

Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin

763

Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial

764

Plasma oxytocin levels in autistic children

765

Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances

766

Plasma parameter investigation during plasma-enhanced chemical vapor deposition of silicon-containing diamond-like carbon films

767

Plasma parameter measurements and deposition of a-Si:H thin films in pulsed ECR plasma.

768

Plasma parameters in pulsed laser-plasma deposition of thin films

769

Plasma parameters of an arc cathode spot at the low-current vacuum discharge

770

Plasma parameters of argon and argon/molecular gas mixture plasmas produced in microwave discharge

771

Plasma paraoxonase, sphingosine1phosphate, total sialic acid, and heat shock protein27 in the liver of the sheep naturally infected with Cysticercus tenuicollis: Evidence on pathological changes

772

Plasma paste boronizing of AISI 8620, 52100 and 440C steels

773

Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47 Original Research Article

774

Plasma penetration depth and mechanical properties of atmospheric plasma-treated 3D aramid woven composites

775

Plasma performance improvements with liquid lithium limiters in CDX-U

776

Plasma peroxidation and α-tocopherol levels in women fed different monoene oils

777

Plasma persistence of 2-aminothiazoline-4-carboxylic acid in rat system determined by liquid chromatography tandem mass spectrometry

778

PLASMA PHARMACOKINETICS AND MUSCLE DISPOSITION OF MARBOFLOXACIN IN CHICKENS

779

Plasma pharmacokinetics and tissue distribution study of physalin D in rats by ultra-pressure liquid chromatography with tandem mass spectrometry

780

Plasma pharmacokinetics of melamine and a blend of melamine and cyanuric acid in rainbow trout (Oncorhynchus mykiss)

781

Plasma pharmacokinetics of pioglitazone following oral or intravenous administration in Holstein cows

782

Plasma pharmacokinetics of warfarin enantiomers in cats

783

Plasma phase oxidation during preparation of oxide superconducting and ferroelectric thin films using pulsed laser deposition

784

Plasma phospholipid fatty acid pattern in severe liver disease

785

Plasma phospholipid fatty acid status and depressive symptoms: Association only present in the clinical range

786

Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus

787

Plasma pinch for final focus and transport

788

Plasma pinch for final focus and transport

789

Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity

790

Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis

791

Plasma plume induced during ArF laser ablation of hydroxyapatite

792

Plasma plume photography and spectroscopy of Fe—Oxide materials

793

Plasma polymer coating in a triode glow discharge

794

Plasma polymer films and their future prospects

795

Plasma polymer films as an alternative to (PSS-PAH)n or (PSS-PDADMAC)n films to retain active enzymes in exponentially growing polyelectrolyte multilayers

796

Plasma polymer thin film depositions to regulate gas permeability through nanoporous track etched membranes

797

Plasma polymerisation of methylphenylsilane

798

Plasma polymerization in a microcapillary using an atmospheric pressure dielectric barrier discharge

799

Plasma polymerization of amine-containing thin films and the studies on the deposition kinetics

800

Plasma polymerization of C4Cl6 and C2H2Cl4 at atmospheric pressure

801

Plasma polymerization of hexamethyldisiloxane: Investigation of the effect of carrier gas related to the film properties

802

Plasma polymerization of hybrid organic–inorganic monomers in an atmospheric pressure dielectric barrier discharge

803

Plasma polymerization of styrene with carbon dioxide under glow discharge conditions

804

Plasma polymerization using a constricted anode plasma source

805

Plasma polymerized allylamine films deposited on 316L stainless steel for cardiovascular stent coatings

806

Plasma polymerized barrier films on membranes for direct methanol fuel cells

807

Plasma polymerized ferrocene films

808

Plasma polymerized hexamethyl disiloxane in adhesion applications

809

Plasma polymerized hexamethyldisiloxane (HMDS) barrier layers

810

Plasma polymerized TEOS films for nanochannels formation and sensor development

811

Plasma polymerized thiophene: molecular structure and electrical properties

812

Plasma polymers with chemically defined structures in contact with metals

813

Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: A significant relationship

814

Plasma porphyrin concentrations in chronic renal failure

815

Plasma position and current control system enhancements for the JET ITER-like wall

816

Plasma position measurement on the Novillo tokamak

817

Plasma post-heparin lipase activities in the HERITAGE family study: the reproducibility, gender differences, and associations with lipoprotein levels

818

Plasma post-oxidation mechanisms of nitrided ferrous alloys

819

Plasma post-oxidation of nitrocarburized SUM 24L steel

820

Plasma post-oxidation process for nitrocarburized layer

821

Plasma potential fluctuations and large quasi-coherent modes observed by a heavy ion beam probe on the JIPP T-IIU tokamak

822

Plasma Potential Measurements by the Heavy Ion Beam Probe Diagnostic in Fusion Plasmas: Biasing Experiments in the TJ-II Stellarator and T-10 Tokamak

823

Plasma powder as cold-set binding agent for meat system: Rheological and Raman spectroscopy study

824

Plasma power source based on a catalytic reaction of atomic hydrogen measured by water bath calorimetry

825

Plasma preconditioning of sapphire substrate for GaN epitaxy

826

Plasma preconditioning of sapphire substrate for GaN epitaxy

827

Plasma Prekallikrein as a Risk Factor for Diabetic Retinopathy

828

Plasma preparation of coal to combustion in power boilers

829

Plasma pressure and the field-aligned currents in the magnetosphere Original Research Article

830

Plasma pressure distribution in the inner magnetosphere and the applicability of Dessler-Parker-Sckopke relation to storm time magnetic disturbance description Original Research Article

831

Plasma pre-treatment and TiO2 coating of PMMA for the improvement of antibacterial properties

832

Plasma pretreatment of the Cu seed layer surface in Cu electroplating

833

Plasma pretreatments for Cu-MOCVD

834

Plasma printing: patterned surface functionalisation and coating at atmospheric pressure

835

Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure

836

Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis

837

Plasma Procalcitonin Levels in Chronic Haemodialysis Patients

838

Plasma process for development of a bulk heterojunction optoelectronic device: A highly sensitive UV detector

839

Plasma processes and film deposition using tetraethoxysilane

840

Plasma processes for wide fabric, film and non-wovens

841

Plasma processes in pulsar magnetospheres

842

Plasma processing for inducing bioactivity in stainless steel orthopaedic screws

843

Plasma processing for surface modification of trivalent chromium as alternative to hexavalent chromium layer

844

Plasma processing of AISI 304 stainless steel using radio frequency hollow cathode discharge

845

Plasma processing of interstellar PAHs into solar system kerogen

846

Plasma processing of materials for medical applications

847

Plasma processing of the Si(0 0 1) surface for tuning SPR of Au/Si-based plasmonic nanostructures

848

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

849

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

850

Plasma processing: a step towards the production of new grades of carbon black Original Research Article

851

Plasma profile and shape optimization for the advanced tokamak power plant, ARIES-AT

852

Plasma profiles and flows in the high-field side scrape-off layer in Alcator C-Mod

853

Plasma profiles in the inner divertor of ASDEX Upgrade

854

Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1

855

Plasma Profiles of Progesterone and Conceptus Proteins in Cows with Spontaneous Embryonic/Fetal Mortality as Diagnosed by Ultrasonography

856

Plasma progesterone changes and length of oestrous cycle in Rusa Deer (Rusa timorensis)

857

Plasma progesterone concentration depends on sampling site in pigs

858

Plasma progesterone concentration in relation to ovulation rate and embryo yield in Chios ewes superovulated with PMSG

859

Plasma progesterone concentrations during early pregnancy in spring- and autumn-bred ewes

860

Plasma progesterone concentrations in the mid-luteal phase are dependent on luteal size, but independent of luteal blood flow and gene expression in lactating dairy cows

861

Plasma progesterone in alpaca (Lama pacos) during pregnancy, parturition and early postpartum

862

Plasma prolactin response to d-fenfluramine in obsessive—compulsive patients before and after fluvoxamine treatment

863

Plasma prolactin, growth hormone and progesterone concentrations in pseudopregnant, hysterectomized and pregnant goats

864

Plasma properties above coronal active regions inferred from SOHO/UVCS and radio spectrograph observations

865

Plasma properties and stoichiometry of laser-deposited BiSrCaCuO thin films

866

Plasma properties from the multi-wavelength analysis of the November 1st 2003 CME/shock event

867

Plasma properties of a new surface-wave-sustained plasma source under the conditions of depositing DLC films

868

Plasma protein adsorption pattern on characterized ceramic biomaterials

869

Plasma Protein and Aggregation Changes in Diabetic Patients

870

Plasma Protein and Soy Fiber Content Effect on Bologna Sausage Properties as Influenced by Fat Level

871

Plasma Protein Binding and Blood-to-Plasma Ratios of Atractylodin and β-Eudesmol, the Bioactive Compounds from Atractylodes lancea (Thunb.) D.C.

872

Plasma protein binding study of oxybutynin by high-performance frontal analysis

873

Plasma protein glycation status in Pakistan type 2 diabetic patients with or without nephropathy

874

Plasma Protein Hydroperoxides During Aging in Humans: Correlation with Paraoxonase 1 (PON1) Arylesterase Activity and Plasma Total Thiols

875

Plasma Protein Lipofuscin-like Fluorophores in Men with Coronary Artery Disease Treated with Statins

876

Plasma Protein Profile of Lactating Women from Two Primary Health Centers in Jakarta, Indonesia

877

Plasma protein therapies: current and future perspectives

878

Plasma protein variations in monozygotic twins discordant for schizophrenia

879

Plasma Proteins in Acute and Chronic Lung Disease of the Newborn

880

Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer

881

Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease

882

Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill

883

Plasma Pyridoxal 5´-Phosphate Level in Children with Intractable and Controlled Epilepsy

884

Plasma quercetin metabolites: structure–antioxidant activity relationships

885

Plasma radiation distribution and radiation loads onto the vessel during transient events in JET

886

Plasma reactions of N2O on hydrogenated amorphous carbon films by PECVD

887

Plasma recovery after various events in HT-7 superconducting tokamak

888

Plasma reduced folates, reproductive performance, and conceptus development in sows in response to supplementation with oxidized and reduced sources of folic acid

889

Plasma Reforming of Aliphatic Hydrocarbons With CO2

890

Plasma reforming of bio-ethanol for hydrogen rich gas production

891

Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases

892

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects Original Research Article

893

Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study

894

Plasma Renin Activity and Plasma Prorenin Are Not Suppressed in Hypertensives Surviving to Old Age

895

Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types

896

Plasma renin activity in the emergency department and its independent association with acute myocardial infarction

897

Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients

898

Plasma renin activity predicts myocardial infarction/revascularization among hypertensive patients

899

Plasma Renin Activity: A Risk Factor for Myocardial Infarction in Hypertensive Patients

900

Plasma resonance of silver nanoparticles deposited on the surface of submicron silica spheres

901

Plasma response models for current, shape and position control in JET

902

Plasma response to a single dose of dietary (beta)-cryptoxanthin esters from papaya (Carica papaya L.) or non-esterified (beta)-cryptoxanthin in adult human subjects: a comparative study

903

Plasma retinol and tocopherol levels in relation to demographic, lifestyle and nutritional factors of plant origin in Greece

904

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study

905

Plasma rich in growth factors in dogs: Two sides of the same coin

906

Plasma rotation and structure of the radial electric field in RFX

907

Plasma rotation under a driven radial current in a tokamak

908

Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment

909

Plasma satellites of X-ray lines of ions in a picosecond laser plasma

910

Plasma scattering measurement using a submillimeter wave gyrotron (gyrotron FU-II) as a power source

911

Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis

912

Plasma scenarios, equilibrium configurations and control in the design of FAST

913

Plasma secondary-neutral and secondary-ion mass spectrometry investigations on ceramic/copper powder pellets

914

Plasma seed priming in green cumin: physiological and developmental study

915

Plasma Selenium Concentration and Glutathione Peroxidase Activity in Breast Cancer Patients Before and After Chemotherapy

916

Plasma selenium concentrations in pregnant women in two countries with contrasting soil selenium levels

917

Plasma selenium in preterm and term infants during the first 12 months of life

918

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

919

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

920

Plasma selenium levels in healthy blood bank donors in the central-eastern part of Belgium

921

Plasma Selenium Measurements in Subjects from Areas with Contrasting Gastric Cancer Risks in Colombia

922

Plasma selenium status in a group of Australian blood donors and fresh blood components

923

Plasma selenium status in children with iron deficiency anemia

924

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

925

Plasma sequestration before cardiopulmonary bypass and cell saving contribute to improved outcome in high-risk cardiac surgical patients

926

Plasma Serotonin and Markers of Bone Formation and Bone Resorption in Hemodialysis Patients

927

Plasma sFas and sFas Ligand Levels in Patients With Thrombotic Thrombocytopenic Purpura and in Those With Disseminated Intravascular Coagulation

928

Plasma sheath behavior and ionic wind effect in electric field modified flames

929

Plasma sheet and magnetosheath plasma mixing in LLBL: Case study Original Research Article

930

Plasma sheet coefficient of diffusion: Predictions and observations Original Research Article

931

Plasma sheet heating during substorm and the values of the plasma sheet diffusion coefficient obtained on the base of interball/tail probe observations Original Research Article

932

Plasma sheet oscillations and their relation to substorm development: Cluster and double star TC1 case study Original Research Article

933

Plasma shield dynamics and target erosion in disruption simulation experiments

934

Plasma shielding effect in laser ablation of metallic samples and its influence on LIBS analysis

935

Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain

936

Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker

937

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

938

Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina

939

Plasma Soluble Osteopontin Concentrations Are Increased in Patients With Rheumatic Mitral Stenosis and Associated With the Severity of Mitral Valve Calcium

940

Plasma source ion implantation using high-power pulsed RF plasma

941

Plasma spheroidization and high temperature stability of lanthanum phosphate and its compatibility with molten uranium

942

Plasma spheroidization of ceramic particles

943

Plasma spheroidization of iron powders in a non-transferred DC thermal plasma jet

944

Plasma spray coating of fly ash pre-mixed with aluminium powder deposited on metal substrates

945

Plasma spray deposition and characterization of strontium zirconate coatings

946

Plasma spray deposition and high temperature characterization of ZrB2–SiC protective coatings

947

Plasma spray deposition of Al-Al2O3 coatings doped with metal oxides: catalytic applications

948

Plasma spray deposition of ultra high temperature ceramics

949

Plasma spray formed near-net-shape MoSi2–Si3N4 bulk nanocomposites—structure property evaluation

950

Plasma spray forming

951

Plasma spray synthesis of La10(SiO4)6O3 as a new electrolyte for intermediate temperature solid oxide fuel cells

952

Plasma spray synthesis of nanomaterial powders and deposits

953

Plasma spray synthesis of nanomaterial powders and deposits

954

Plasma spray synthesis of ultra-fine YSZ powder

955

Plasma sprayed Al2O3/FeCrAl composite coatings for electromagnetic wave absorption application

956

Plasma sprayed and laser engraved field electron emitters

957

Plasma sprayed coatings for RF wave absorption

958

Plasma sprayed composite coatings obtained by liquid injection of secondary phases

959

Plasma sprayed gadolinium zirconate thermal barrier coatings that are resistant to damage by molten Ca–Mg–Al–silicate glass

960

Plasma sprayed hydroxyapatite coatings from nanostructured granules

961

Plasma sprayed hydroxyapatite coatings on titanium substrates Part 1: Mechanical properties and residual stress levels

962

Plasma sprayed hydroxyapatite coatings on titanium substrates Part 2: optimisation of coating properties

963

Plasma sprayed metal supported YSZ/Ni–LSGM–LSCF ITSOFC with nanostructured anode

964

Plasma sprayed Mo–Mo oxide nanocomposites: synthesis and characterization

965

Plasma sprayed steel: Adhesion of an alumina film via a wüstite interlayer

966

Plasma sprayed TiB2–Ni cermet coatings: Effect of feedstock characteristics on the microstructure and tribological performance

967

Plasma sprayed TiO2: The influence of power of an electric supply on particle parameters in the flight and character of sprayed coating

968

Plasma sprayed TiO2: The influence of power of an electric supply on relations among stoichiometry, surface state and photocatalytic decomposition of acetone

969

Plasma sprayed tungsten-based coatings and their performance under fusion relevant conditions

970

Plasma sprayed wollastonite/TiO2 composite coatings on titanium alloys

971

Plasma Spraying and Characterization of Chromium Carbide-Nickel Chromium Coatings

972

Plasma spraying modeling: Particle injection in a time-fluctuating plasma jet

973

Plasma spraying of Al2O3–WO3 composite coatings

974

Plasma spraying of efficient photoactive TiO2 coatings

975

Plasma spraying of functionally graded hydroxyapatite/Ti–6Al–4V coatings

976

Plasma spraying of lanthanum silicate electrolytes for intermediate temperature solid oxide fuel cells (ITSOFCs)

977

Plasma spraying of porous nanostructured TiO2 film

978

Plasma spraying of submicron ceramic suspensions using a continuous ink jet printer

979

Plasma startup by neutral beam injection in the Large Helical Device

980

Plasma status of retinol, α- and γ-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study

981

Plasma status of selected minerals in hypertensive men with and without insulin resistance

982

Plasma sterilization using glow discharge at atmospheric pressure

983

Plasma sterilization using the RF glow discharge

984

Plasma steroid concentrations in relation to reproductive performance in Thoroughbred stallions

985

Plasma steroid concentrations in relation to reproductive performance in Thoroughbred stallions

986

Plasma steroid hormone concentrations and blood flow of the ovarian structures of the female dromedary (Camelus dromedarius) during growth, dominance, spontaneous ovulation, luteinization and regression of the follicular wave

987

Plasma steroid levels in female flounder (Platichthys flesus) after chronic dietary exposure to single polycyclic aromatic hydrocarbons

988

Plasma stream homogeneity in metal plasma immersion ion implantation and deposition

989

Plasma structures and transport in the SOL of the T-10 tokamak

990

Plasma structures at weakly outgassing comets—results from bi-ion fluid analysis

991

Plasma study and deposition of DLC/TiC/Ti multilayer structures using technique combining pulsed laser deposition and magnetron sputtering

992

Plasma study of a moly-oxide-argon discharge bulb

993

Plasma substance P and soluble P-selectin as biomarkers of β-thalassemia induced hypercoagulability

994

Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock

995

Plasma suppression of beam–beam interaction in a muon collider

996

Plasma suppression of beam–beam interaction in a muon collider

997

Plasma surface alloying of spheroidal graphite iron

998

Plasma surface engineering in first wall of tokamak

999

Plasma surface engineering in the automotive industry—trends and future prospectives

1000

Plasma surface functionalization and dyeing kinetics of Pan-Pmma copolymers

بازگشت